John Wilson

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Four Vanderbilt University engineering faculty members have been elected to the 2024 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More